The Comparative Effectiveness of Innovative Treatments for Cancer (CEIT-Cancer) project: Rationale and design of the database and the collection of evidence available at approval o... by Ladanie, A, Speich, B, Naudet, F, Agarwal, A, Pereira, T, Sclafani, F, Martin-Liberal, J, Schmid, T, Ewald, H, Ioannidis, J, Bucher, H, Kasenda, B, Hemkens, L

Rationale and design of the POLEM trial: avelumab plus fluoropyrimidine-based chemotherapy as adjuvant treatment for stage III mismatch repair deficient or POLE exonuclease domain... by Lau, D, Kalaitzaki, E, Church, DN, Pandha, H, Tomlinson, I, Annels, N, Gerlinger, M, Sclafani, F, Smith, G, Begum, R, Crux, R, Gillbanks, A, Wordsworth, S, Chau, I, Starling, N, Cunningham, D, Dhillon, T